Creso Pharma - A Global Cannabis and Psychedelics Powerhouse in the Making, page-46

The global market for Psychedelics is whoever is being treated for depression, anxiety, eating disorders, epilepsy, PTSD to name a few, which is roughly 20% of the 1st world population.

There are currently over a 100 clinical trials worldwide in Psychedelics in various stages. Most are showing up to 70% remission, where antidepressants at best are 30%.

America already have fast tracked psychedelics into the community through the FDA break through therapies, that is therapies that show significant improvement in symptoms. Australia also has a similar scheme.

To have a debate both parties need to be talking about a subject they know about. I know about Psychedelic Assist Therapy.

It's obvious you do not.